Zobrazeno 1 - 10
of 4 851
pro vyhledávání: '"Georgiadis, D."'
Autor:
Devel L; CEA, INRAE, Médicaments et Technologies pour la Santé (MTS), SIMoS, Université Paris-Saclay, 91191, Gif-sur-Yvette, France., Malgorn C; CEA, INRAE, Médicaments et Technologies pour la Santé (MTS), SIMoS, Université Paris-Saclay, 91191, Gif-sur-Yvette, France., Tohon RW; CEA, INRAE, Médicaments et Technologies pour la Santé (MTS), SIMoS, Université Paris-Saclay, 91191, Gif-sur-Yvette, France., Launay M; CEA, INRAE, Médicaments et Technologies pour la Santé (MTS), SIMoS, Université Paris-Saclay, 91191, Gif-sur-Yvette, France., Patiniotis K; Department of Chemistry, Laboratory of Organic Chemistry, University of Athens, Panepistimiopolis, Zografou, 15771, Athens, Greece., Sejalon-Cipolla M; IBMM, Univ. Montpellier, ENSCM, CNRS, Montpellier, France., Beau F; CEA, INRAE, Médicaments et Technologies pour la Santé (MTS), SIMoS, Université Paris-Saclay, 91191, Gif-sur-Yvette, France., Thai R; CEA, INRAE, Médicaments et Technologies pour la Santé (MTS), SIMoS, Université Paris-Saclay, 91191, Gif-sur-Yvette, France., Bruyat P; CEA, INRAE, Médicaments et Technologies pour la Santé (MTS), SIMoS, Université Paris-Saclay, 91191, Gif-sur-Yvette, France., Bonino A; CEA, INRAE, Médicaments et Technologies pour la Santé (MTS), SIMoS, Université Paris-Saclay, 91191, Gif-sur-Yvette, France., Bregant S; CEA, INRAE, Médicaments et Technologies pour la Santé (MTS), SIMoS, Université Paris-Saclay, 91191, Gif-sur-Yvette, France., Subra G; IBMM, Univ. Montpellier, ENSCM, CNRS, Montpellier, France., Cantel S; IBMM, Univ. Montpellier, ENSCM, CNRS, Montpellier, France., Georgiadis D; Department of Chemistry, Laboratory of Organic Chemistry, University of Athens, Panepistimiopolis, Zografou, 15771, Athens, Greece.
Publikováno v:
Chembiochem : a European journal of chemical biology [Chembiochem] 2024 Dec 02; Vol. 25 (23), pp. e202400441. Date of Electronic Publication: 2024 Nov 06.
Autor:
Papadopoulou D; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', 16672, Vari, Greece., Mavrikaki V; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', Vari, 16672, Athens, Greece.; Department of Chemistry, Laboratory of Organic Chemistry, National and Kapodistrian University of Athens, 15784, Athens, Greece., Charalampous F; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', 16672, Vari, Greece., Tzaferis C; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', 16672, Vari, Greece., Samiotaki M; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', 16672, Vari, Greece., Papavasileiou KD; Department of ChemoInformatics, Novamechanics Ltd., 1070, Nicosia, Cyprus.; Department of Chemoinformatics, Novamechanics MIKE, 18545, Piraeus, Greece.; Division of Data Driven Innovation, Entelos Institute, 6059, Larnaca, Cyprus., Afantitis A; Department of ChemoInformatics, Novamechanics Ltd., 1070, Nicosia, Cyprus.; Department of Chemoinformatics, Novamechanics MIKE, 18545, Piraeus, Greece.; Division of Data Driven Innovation, Entelos Institute, 6059, Larnaca, Cyprus., Karagianni N; Biomedcode Hellas S.A., 16672, Vari, Greece., Denis MC; Biomedcode Hellas S.A., 16672, Vari, Greece., Sanchez J; Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, NG7 2UH, Nottingham, U.K.; Centre of Membrane Proteins and Receptors, Universities of Birmingham and Nottingham, NG2 7AG, Midlands, U.K., Lane JR; Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, NG7 2UH, Nottingham, U.K.; Centre of Membrane Proteins and Receptors, Universities of Birmingham and Nottingham, NG2 7AG, Midlands, U.K., Faidon Brotzakis Z; Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, U.K.; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', 16672, Vari, Greece., Skretas G; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', 16672, Vari, Greece.; Institute of Chemical Biology, National Hellenic Research Foundation, 11635, Athens, Greece., Georgiadis D; Department of Chemistry, Laboratory of Organic Chemistry, National and Kapodistrian University of Athens, 15784, Athens, Greece., Matralis AN; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', 16672, Vari, Greece., Kollias G; Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', 16672, Vari, Greece.; Department of Physiology, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece.; Research Institute of New Biotechnologies and Precision Medicine, National and Kapodistrian University of Athens, 11527, Athens, Greece.
Publikováno v:
Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2024 Apr 02; Vol. 63 (14), pp. e202319157. Date of Electronic Publication: 2024 Feb 26.
Endoplasmic reticulum aminopeptidase 2 (ERAP2) is an intracellular enzyme involved in the processing of antigenic peptides intended for presentation by major histocompatibility complex class I (MHCI) molecules. Because of its role in regulating immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::3637a5476b2c1e45191ad4f491bcd0d6
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020011
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020011
Autor:
Temponeras, I. Stamatakis, G. Samiotaki, M. Georgiadis, D. Pratsinis, H. Panayotou, G. Stratikos, E.
Recent studies have linked the activity of ER aminopeptidase 2 (ERAP2) to increased efficacy of immune‐checkpoint inhibitor cancer immunotherapy, suggesting that pharmacological inhibition of ERAP2 could have important therapeutic implications. To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::45d6514d21a1c5800b47026212e1d8a5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2980539
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2980539
In this report, a synthetic protocol for the preparation of phosphinic dipeptides of type 5 is presented. These compounds serve as valuable building blocks for the development of highly potent phosphinopeptidic inhibitors of medicinally relevant Zn-m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::91033f7e5fe0d8e02b74e780d723bef1
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020017
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020017
Autor:
Lelis A; Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15784 Athens, Greece., Skoulikas N; Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15784 Athens, Greece., Papathanasopoulou M; Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15784 Athens, Greece., Voreakos K; Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15784 Athens, Greece., Georgiadis D; Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15784 Athens, Greece.
Publikováno v:
Organic letters [Org Lett] 2023 Sep 15; Vol. 25 (36), pp. 6623-6627. Date of Electronic Publication: 2023 Sep 05.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Georgiadis, D1, Schulte-Mattler, W. J1
Publikováno v:
Acta Neurologica Scandinavica. Apr2002, Vol. 105 Issue 4, p337-340. 4p. 3 Graphs.
Activity-based probes enable discrimination between the active enzyme and its inactive or inactivated counterparts. Since metalloproteases catalysis is non-covalent, activity-based probes targeting them have been systematically developed by decoratin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::70bc439f73ff5284bb09ba25a44c41d2
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2980703
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2980703
The chiral N1-Cbz, N2-H derivative of the piperazic acid monomer is a valuable building block in the total synthesis of natural products, comprising this nonproteinogenic amino acid. In that context, we wish to report an improved synthetic protocol f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::651ba16043698790a21e7529dd7cd427
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020601
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020601